Skip to main content
. 2023 Oct 16;13(10):e075136. doi: 10.1136/bmjopen-2023-075136

Figure 2.

Figure 2

Dose–response relationships between time of PPI use and kidney stones: (A) time of PPI use and kidney stones; (B) time of PPI use and recurrent kidney stones. Adjusted for age, sex, race, education level, smoking, alcohol consumption, BMI, mean arterial pressure, HbA1c, triglycerides, history of CVD, gout, thiazide use, loop diuretic use and H2RA use, sedentary time, total water intake, albumin-adjusted calcium and eGFR. The shaded part represents the 95% CI. BMI, body mass index; CVD, cardiovascular disease; eGFR, estimated glomerular filtration rate; H2RA, histamine-2 receptor antagonist; PPIs, proton pump inhibitors.